Sitemap
Start Page  »  Sitemap
About Karo Bio
Business Model
Company History
1987 - 2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
Board of Directors
Executive Management
Organization
Principal Shareholders
Corporate Governance
Board of Directors and President
Work of the Board of Directors
Audit
Nominating Committee
By-Laws
General Meetings
Stock Option Programs
Financial Reports
Corporate Citizenship
Contact Karo Bio
Map
Company Email certificates
Glossary
Research & Development
Our R&D capabilities
Collaboration strategy
Therapeutic Areas
CNS releated disorders, incl. depression
Dyslipidemia– high blood lipids
Estrogen and women's health
Type 2 diabetes
Other therapeutic areas
Our pipeline Portfolio
Eprotirome
KB3305
ER-beta
Partner Projects
Intellectual Property
Trademarks
Publications
Karo Bio's Research Foundation
Scientific Contact
Glossary
IR & Media
Investor / Media Contact
Stock Price Information
Financial Information & Reports
Annual Reports
Interim Reports and Full Year Reports
Prospectuses and Supplements
Analysts
Press Releases
News and Updates
Events/Presentations
General Meetings
Board of Directors
Executive Management
Image Library
Principal Shareholders
Subscription Service
Investor / Media
Partnering
Partnering Contact
Partnerships
Merck & Co., Inc. - Estrogen Receptors
Zydus Cadila - Inflammation
Wyeth Pharmaceuticals - Inflammation
Career Opportunities
Vacant positions
Contact Human Resources